Business
Bio Spectrum
India's Pharma Reforms Target Global Credibility
The Indian government has introduced several measures to simplify drug approvals and support innovation.
9 min |
October 2025
Bio Spectrum
How Waste Management Strategies Can Transform Indian Pharma Manufacturing
Sustainability will be a key success factor as India's pharmaceutical industry enters its next stage of expansion.
7 min |
October 2025
Bio Spectrum
IASST synthesises new compound to combat aggressive breast cancer
A newly designed nitro-substituted organoselenium compound by Guwahati-based Institute of Advanced Study in Science and Technology (IASST), an autonomous institute under the Department of Science and Technology (DST), can reduce the invasiveness of aggressive triplenegative breast cancer cells by modulating various Se Se signalling pathways.
1 min |
October 2025
Bio Spectrum
DPIIT signs MoU with Pfizer to strengthen healthcare innovation ecosystem
In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has signed a Memorandum of Understanding (MoU) with Pfizer Limited.
1 min |
October 2025
Bio Spectrum
WHO unveils updated guideline on HIV service delivery
WHO has released an updated guideline to support integrated HIV service delivery, promote long-term adherence to antiretroviral therapy (ART), and improve the overall health and well-being of people living with HIV.
1 min |
October 2025
Bio Spectrum
Scientists in Kolkata explore therapeutic potential of accessory proteins
A hidden protein that protects our cells from mechanical stress could provide a new direction to therapeutic strategies for diseases where protein stability under force is compromised like heart muscle disease or genetic disorders called laminopathies.
1 min |
October 2025
Bio Spectrum
US FDA advances rare disease drug development
The US Food and Drug Administration (FDA) has introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect.
1 min |
October 2025
Bio Spectrum
WHO updates list of essential medicines to include key cancer, diabetes treatments
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLC), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.
1 min |
October 2025
Bio Spectrum
Agilent's MMR IHC Panel pharmDx (Dako Omnis) receives European IVDR Certification
Agilent Technologies Inc. has announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer.
1 min |
October 2025
Bio Spectrum
Aodh Lifesciences gets support from TDB to redefine pneumonia treatment
The Technology Development Board (TDB), Department of Science and Technology, Government of India, has extended support to Aodh Lifesciences, a startup based in Hyderabad, for development of Indigenous Antibiotic Nebulisation Suspension for Pneumonia (AONEUM-04) and Antimicrobial Resistance (AMR).
1 min |
October 2025
Bio Spectrum
Antara Senior Care names Mukesh Ghuraiya as Chief Marketing Officer
Antara Senior Care, a fully integrated senior care ecosystem, has appointed Mukesh Ghuraiya as the Executive Vice-President and Chief Marketing Officer (CMO).
1 min |
October 2025
Bio Spectrum
Poly Medicure acquires PendraCare Group for Rs 188.5 Cr
Poly Medicure, a Delhi-based medical device company, has announced signing of definitive agreements to acquire 90 per cent stake in PendraCare Group consisting of PendraCare Holdings and Welling Medical from Welling Holdings B.V. at an Enterprise value of Rs 188.5 crore (Euro 18.3 million).
1 min |
October 2025
Bio Spectrum
ShardaCare Healthcity ropes in Dr Kousar Shah as Group CEO
ShardaCare Healthcity has appointed Dr Kousar Shah as the Group Chief Executive Officer (CEO), effective immediately.
1 min |
October 2025
Bio Spectrum
PAHO launches tool to monitor early child development in Latin America
The Pan American Health Organization (PAHO) has released the Spanish version of a package of measures to monitor child development up to 36 months of age.
1 min |
October 2025
Bio Spectrum
IIT-M and Danish University study reveals genetic 'switches' to transform disease research
Researchers at the Indian Institute of Technology Madras (IIT-M) and Danish University have shown how interactions between genetic variants can act like \"switches\" to unlock hidden cellular pathways.
1 min |
October 2025
Bio Spectrum
Platinum Rx raises $6 M to expand affordable medicine access in India
Bengaluru-based startup PlatinumRx, an online pharmacy making quality medicines affordable for chronic patients, has raised $6 million in a Series A round led by Stellaris Venture Partners, with participation from existing investor India Quotient.
1 min |
October 2025
Bio Spectrum
Cohance Lifesciences invests $10 M in cGMP Bioconjugation Suite in US
Hyderabad-based Cohance Lifesciences, a leading global Contract Research, Development & Manufacturing Organisation (CRDMO), has announced a strategic investment of $10 million to expand cGMP bioconjugation capabilities at its US based subsidiary, NJ Bio.
1 min |
October 2025
Bio Spectrum
GN Hearing India appoints new Country Managing Director
GN Hearing, a subsidiary of Denmark-based GN Group, has appointed Anju Kadam as its Country Managing Director for India.
1 min |
October 2025
Bio Spectrum
Revitalising Cosmetic Standards & Compliance
A huge craze among consumers for cosmeceuticals, by going into marketing and brand appeal, is setting a dangerous precedent.
6 min |
October 2025
Bio Spectrum
DBT-BIRAC unveils high performance biomanufacturing platforms
The Department of Biotechnology (DBT), Government of India, and the Biotechnology Industry Research Assistance Council (BIRAC) have announced the launch of India's first Biofoundry Network, a landmark initiative aimed at transforming the country's biotechnology landscape and achieving a $300 billion bioeconomy by 2030.
1 min |
October 2025
Bio Spectrum
WHO announces development of guidelines on multiplex testing
The World Health Organisation (WHO) is convening a Guideline Development Group (GDG) for the development of evidence-based recommendations on multiplex testing which will establish critical principles for integrated testing and address latest evidence specific to HIV, viral hepatitis and sexually transmitted infections (STIs).
1 min |
October 2025
Bio Spectrum
Of Tariffs Reform & Resilience
Despite being under the looming threat of higher US tariffs on medicine imports—possibly as steep as 200 per cent, the Indian pharmaceutical sector has reasons to stay optimistic.
2 min |
October 2025
Bio Spectrum
i-Hub Gujarat and India Accelerator launch Sanjeevan Healthcare Accelerator Programme
i-Hub Gujarat, the state's flagship startup and innovation hub under the Education Department, Government of Gujarat, in collaboration with India Accelerator (IA), India's leading fund-led accelerator, has launched the Sanjeevan Healthcare Accelerator Programme, a 12-week initiative to nurture and scale promising healthcare startups.
1 min |
October 2025
Bio Spectrum
Canon Medical Systems India lays focus on advanced cancer diagnostics
Canon Medical Systems India has announced the signing of a Memorandum of Understanding (MoU) with Rajiv Gandhi Cancer Institute & Research Centre, further strengthening its footprint in the medical segment.
1 min |
October 2025
Bio Spectrum
Can DPDPA's Research Exemption Power Private Sector Breakthroughs?
India's Digital Personal Data Protection Act, 2023 (DPDPA), imposes uniform data protection obligations across sectors, significantly affecting healthcare, pharma, and biotech firms due to their use of sensitive personal data. Section 17(2) (b) provides limited exemptions for \"research, archiving, or statistical purposes,\" which some stakeholders interpret as broad immunity.
4 min |
October 2025
Bio Spectrum
The Science Behind Peak Athletic Performance
Focusing on how the body works during physical exercise and how sport and physical activity encourage physical, social, and mental health, the concept of sports science and technology is garnering more attention than ever across the world.
2 min |
October 2025
Bio Spectrum
Engineering Contamination Out: Product-Led Innovation for a Safer, Smarter Pharma Floor
Across the pharmaceutical industry, regulatory auditors are voicing a consistent message: manual intervention must go. With new global guidelines such as EU GMP Annex 1 placing heightened emphasis on contamination control, manufacturers, particularly in sterile operations, are being urged to challenge longstanding practices.
2 min |
October 2025
Bio Spectrum
Somerset Indus Capital Partners powers ahead as Fund III nears $250 M close
Somerset Indus Capital Partners has announced that Fund III is in the final stages of its close, nearing ~$250 million, with documentation completion underway.
1 min |
October 2025
Bio Spectrum
New global collaboration uses experts and AI to spot next pandemic
Global health and pandemic experts are banding together to combine their AI programmes and infectious disease knowledge to more accurately rank the viruses that have the potential to cause the next deadly pandemic.
1 min |
October 2025
Bio Spectrum
Revvity establishes in vivo imaging Centre of Excellence in North Carolina
Revvity, Inc. has announced the opening of its new In Vivo Imaging Centre of Excellence in Morrisville, North Carolina, the heart of the state's Research Triangle.
1 min |